Michigan Cancer Consortium

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Carl Pfadt: Fighting sarcoma, the forgotten cancer

Often called the “forgotten cancer,” sarcoma refers to more than 70 subtypes of cancer that affect the body’s connective tissue. "Sarcomas are rar...

Read More

Karmanos researchers look to cancer studies to understand racial disparities in health care

Cancer and COVID-19 vary vastly in their classification, treatment and symptoms but the two have something in common: they are disproportionately ...

Read More

Karmanos launches COVID-19, Cancer & Community survey to assess the impact of COVID-19 response on the health habits of Michiganders

Karmanos Cancer Institute has launched a survey to ask community members about their experiences with health care during the COVID-19 pandemic. Qu...

Read More